Literature DB >> 25917068

Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania.

Maximilian Gahr1, Florian Lauda1, Moritz E Wigand2, Bernhard J Connemann1, Angela Rosenbohm2, Hayrettin Tumani2, Markus Reindl3, Zeljko Uzelac1, Jan Lewerenz2.   

Abstract

Several findings suggest that there may be an overlap of anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis with neuromyelitis optica spectrum disorders or acute demyelinating encephalomyelitis (ADEM)-like demyelination. We present a case of a patient with anti-NMDAR antibody encephalitis, who on MRI featured a single prominent T2-hyperintensive white matter lesion in the periventricular region, adjacent to the anterior horn of the left lateral ventricle. In view of the lesion location and the cerebrospinal fluid (CSF) findings (incomplete MRZ (measles, rubella and varicella zoster) reaction, lymphocytic pleocytosis, intrathecal IgG and IgM synthesis; absence of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies), the presence of a multiple sclerosis-like immune response was discussed. This case appears to add evidence to the hypothesis of an overlap between anti-NMDAR antibody encephalitis and other inflammatory central nervous system diseases. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917068      PMCID: PMC4422915          DOI: 10.1136/bcr-2014-209075

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; S Rauer; K P Wandinger; H F Petereit; M Maurer; H Tumani; A Vincent; P Eichhorn; B Wildemann; M Wick; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-12       Impact factor: 10.154

2.  Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Authors:  Frank Leypoldt; Romana Höftberger; Maarten J Titulaer; Thaís Armangue; Nuria Gresa-Arribas; Holger Jahn; Kevin Rostásy; Wolfgang Schlumberger; Thomas Meyer; Klaus-Peter Wandinger; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

3.  Clinical and neurochemical characteristics of pediatric multiple sclerosis - CSF analysis as knowledge base for differential diagnosis and pathophysiology.

Authors:  Kevin Rostasy; Hansotto Reiber
Journal:  Acta Neuropsychiatr       Date:  2009-06       Impact factor: 3.403

Review 4.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

5.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

6.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

7.  The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

Authors:  Johannes Brettschneider; Anne Czerwoniak; Makbule Senel; Lubin Fang; Jan Kassubek; Elmar Pinkhardt; Florian Lauda; Tamara Kapfer; Sarah Jesse; Vera Lehmensiek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

8.  The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity?

Authors:  Sven Jarius; Peter Eichhorn; Christian Jacobi; Brigitte Wildemann; Manfred Wick; Raymond Voltz
Journal:  J Neurol Sci       Date:  2008-11-28       Impact factor: 3.181

9.  The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis.

Authors:  H Reiber; S Ungefehr; C Jacobi
Journal:  Mult Scler       Date:  1998-06       Impact factor: 6.312

10.  NMDA receptor antibodies associated with distinct white matter syndromes.

Authors:  Yael Hacohen; Michael Absoud; Cheryl Hemingway; Leslie Jacobson; Jean-Pierre Lin; Mike Pike; Sunil Pullaperuma; Ata Siddiqui; Evangeline Wassmer; Patrick Waters; Sarosh R Irani; Camilla Buckley; Angela Vincent; Ming Lim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-04-24
View more
  2 in total

Review 1.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

Review 2.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.